INTRODUCTION
Platelet formation by megakaryocytes (MKs) requires an ordered sequence of differentiation steps from haematopoietic stem cells followed by MK maturation, during which repeated rounds of DNA replication without cell division usually result in very large MKs with a single nucleus and DNA contents up to 128N. This process enables the accumulation of platelet-specific granules and an invaginated membrane system that will later contribute to the platelet cytoplasmic contents and surface membrane. 1, 2 Platelets are generated from mature MKs by the protrusion of cytoplasmic extensions termed proplatelets into bone marrow sinusoids, where final platelet sizing and shaping occurs. 3 Platelet formation strongly depends on microtubules, which enable proplatelet elongation and transport of organelles from the MK cytoplasm, 1 and actindependent processes, which mediate the branching of elongating proplatelets, thereby determining the number of available proplatelet tips to form platelets. 4 Altered regulation of platelet formation is a feature of several human hematopoietic disorders, including macrothrombocytopenia (MTP) in which there are enlarged and reduced numbers of circulating platelets, sometimes resulting in abnormal bleeding. 5, 6 underlie associated phenotypes such as hearing loss, cataract and glomerulopathy with some MYH9 variants 10, 16 and periventricular nodular heterotopia and otopalatodigital syndromes with some FLNA variants. 8 Here we extend the repertoire of MTP by reporting the discovery of a new dominant syndromic disorder of platelet formation. We show that MTP was associated with sensorineural hearing loss in two unrelated pedigrees and that this phenotype segregates with the same chain-truncating variant in DIAPH1, which encodes the cytoskeletal regulator and Rho-effector, diaphanous-related formin 1 (DIAPH1, mDia1), identified previously as a regulator of megakaryocytopoiesis in vitro. 17 
METHODS

Recruitment of cases and genetic analysis.
The cases were enrolled to the BRIDGE-BPD study (UK REC10/H0304/66) or French 'Network on the inherited diseases of platelet function and platelet production' (INSERM RBM 04-14) after providing informed written consent. Control groups comprised other cases with bleeding or platelet disorders (BPD) of unknown genetic basis or with unrelated rare disorders enrolled to the NIHR BioResource-Rare Diseases study (UK REC 13/EE/0325). Data collection, human phenotype ontology (HPO) coding and high throughput sequencing were performed as previously reported. 18 Splice site, frameshift, stop-gain/loss or start-loss variants were analyzed further if they were less frequent than 1 in 10,000 in the Exome Aggregation Consortium (ExAC) database and 1 in 100 in our in-house database. Candidate genes for BPD were identified by phenotype similarity regression 19 to allow for the high degree of phenotypic and genetic heterogeneity amongst the BPD cases.
Platelet imaging
Fixed peripheral blood smears were stained with May-Grünwald-Giemsa stain (MGG). Transmission electron microscopy was performed on platelets fixed with 2.5% glutaraldehyde. Platelet characteristics were measured in a minimum of 99 sections for each case using ImageJ as described previously. 8 Data are presented as mean ± SD. Statistical significance was determined by Student's t test for continuous variables, and by the χ² test for categorical variables. P<0.01 was considered as statistically significant.
Megakaryocyte colony culture and analysis
CD34 + hematopoietic stem cells (HSCs) were isolated from peripheral blood by magnetic cell sorting and differentiated into MKs as described previously in plate and liquid cultures. 20,21 MK-colony forming units (MK-CFU) and MKs were visualized by light or confocal microscopy after staining with MGG, phalloidin or anti-CD61
antibodies. Proplatelet formation (PPF) in liquid MK cultures was determined by light microscopy and ploidy by flow cytometry as described previously. 21
DIAPH1 expression in cell lines
The DIAPH1-R1213* cDNA was generated by site directed mutagenesis of the fulllength wild-type DIAPH1 cDNA and cloned into the pCMV6-Fc-S (Origene, Rockville, MD) mammalian expression vector, before transient transfection into human embryonic kidney (HEK293FT) or adenocarcinomic human alveolar basal epithelial (A549) cells, cultured using standard conditions.
Western blotting and immunofluorescence microscopy
Denatured washed platelet or transfected HEK293FT cell lysates were separated by SDS-PAGE and blotted onto PVDF membranes. The membranes were probed with primary antibodies recognizing DIAPH1, DIAPH3, DIAPH2, GAPDH, β-, tyrosinated (Tyr-), detyrosinated (Glu-) and acetylated tubulin (ac-tubulin).
For confocal microscopy, transfected A549 cells or platelets applied to fibrinogencoated coverslips were fixed and probed with antibodies recognizing tubulin or DIAPH1 as described above. Filamentous actin was stained using phalloidinAtto647N. Where indicated, platelets were pre-incubated with 10 µM colchicine.
Platelets and cells were visualized by confocal microscopy as reported previously. 22
Microtubule sedimentation and cold-induced disassembly
Polymerized and soluble microtubule fractions were prepared from lysates of resting or colchicine-treated (10 µM) platelets and from resting or SMIFH2-treated (25 µM) transfected HEK293FT cells by centrifugation for 30 min at 100,000 g and 37°C.
Microtubule fractions were visualized by Western blot. Microtubules were depolymerized by incubation of platelets at 4°C or with colchicine (10 µM).
Reassembly was allowed by subsequent rewarming at 37°C as previously reported.
22-24
Detailed methods and uncropped images of Western blots are provided in Supplementary material.
RESULTS
Selection of DIAPH1 as a candidate gene for MTP
We identified DIAPH1 as a novel candidate gene for MTP by analyzing data from 702 index cases with bleeding or platelet disorders of unknown genetic basis recruited to BRIDGE-BPD study of the NIHR Bioresource-Rare Diseases. Control data were analyzed from 3,453 cases with unrelated rare disorders or unaffected pedigree members recruited to other branches of the NIHR Bioresource-Rare Diseases.
There were 1,073 genes for which at least two BPD cases carried a rare variant predicted to have a high impact on gene translation. After phenotype similarity regression analysis of the genes in this group, DIAPH1 had the highest probability for the model specifying a statistical association between phenotype and genotype for which thrombocytopenia was inferred (mean (γ)=0.81; Fig. 1A ) The inferred characteristic phenotype for DIAPH1 primarily comprised the HPO terms "Sensorineural hearing impairment" and "Abnormality of blood and blood-forming tissues", with the latter driven by the terms "Thrombocytopenia" and "Abnormal bleeding" (Fig. 1B) . Fig. 2 ). This variant was not observed in any of the 61,486 exomes in the ExAC database nor in the remaining 4,151 exomes sequenced in-house. Sanger sequencing showed that the R1213* variant was present in six further pedigree members with both MTP and sensorineural hearing loss but was absent in three asymptomatic pedigree members, indicating segregation with the DIAPH1 genotype (p=3.66 × 10 -4 , conditional on the genotypes of the index cases; Fig. 1C ). We found no other rare variants shared by the index cases within 10 Mb around DIAPH1. The sequencing data provided no evidence that these cases were closely related at genome-wide level or more locally within the DIAPH1-containing chromosome 5
( Supplementary Fig. 1 ).
The R1213* variant predicts DIAPH1 protein truncation DIAPH1 is a homodimeric formin family protein that promotes actin assembly and regulates microtubule stability through a formin homology (FH) 1 domain which contains binding sites for profilin, and an FH2 domain which promotes nucleation and elongation of actin filaments and possibly microtubule interactions. 25-27 DIAPH1 is regulated by a diaphanous auto-regulatory domain (DAD) near the carboxyl terminus, which inhibits DIAPH1 activity through an interaction with the diaphanous inhibitory domain (DID) near the amino terminus (Fig. 2) . Auto-inhibition is normally released by competitive binding of activated Rho GTPases, enabling cytoskeletal remodeling. 28, 29 The inhibitory DAD-DID interaction is mediated by 'core' MDxLLExL and 'basic' RRKR motifs in the DAD (Fig. 2) that bind cognate DID sequences. 30 Reverse-transcriptase (RT) PCR and amplification of the R1213 region with subsequent restriction endonuclease digestion proved the presence of both wild-type and R1213* DIAPH1 mRNA transcripts in platelets from cases 10 and 16 ( Supplementary Fig. 2 ). The premature stop codon created by the R1213* variant occurs at position 1 of the RRKR motif (residues 1213-1216), but is closer to the DIAPH1 carboxyl terminus than the MDxLLExL motif (residues 1199-1206).
Therefore, the predicted consequence of the R1213* variant is expression of DIAPH1 protein with a truncation within the DAD resulting in loss of the RRKR motif, but not the MDxLLExL motif (Fig. 2) . DIAPH1 R1213* is associated with syndromic MTP and hearing loss and frequently with mild neutropenia All eight genotyped R1213* cases had thrombocytopenia (baseline automated platelet counts 63-147 x10 9 L -1 ) and enlarged platelets (mean platelet volume (MPV) 11.2-14.1 fL), confirmed by light microscopy (Fig 3A. and Table 1 ) and by morphometric analysis of platelet electron micrographs ( Table 2 ). The platelet count ranges in the male and female cases corresponded to the 0.15-2.81 th percentiles and 0.08-0.38 th percentiles respectively of a sex-stratified population of 443,142 UK BioBank volunteers. For MPV, the corresponding percentiles were 99.81-99.83 and 94.14-99.92 (Supplementary Fig. 3 ). Asymptomatic mild neutropenia was observed on at least one occasion in six cases (range of neutrophil counts 0.62-4.34 x10 9 L -1 ), but varied within the cases at different times ( Table 1) . Four cases displayed iron deficiency anemia, which corrected completely with dietary iron supplementation. The other cases had no red cell abnormalities suggesting that the erythroid lineage was unaltered by the R1213* variant. Platelets from three tested cases showed normal aggregation with ADP (2.5-10 µM), collagen (2 µg mL -1 ), arachidonic acid (0.5 mg mL -1 ), TRAP-14mer (50 µM) and ristocetin (0.5-1-5 mg mL -1 ). ADP and TRAP-stimulated dense granule secretion (cases 10, 16, 17 and 21) and α-granule secretion (cases 10 and 16) were unchanged compared to controls. Platelet surface expression of αIIbβ3 integrin and glycoprotein Ib-IX-V (cases 10, 16 and 17) was slightly increased compared with controls, consistent with the increased platelet size. Electron microscopy (cases 10, 16, 17 and 21) showed that the enlarged platelets were typically round, although occasionally highly elongated. There were also abnormal vacuoles, membrane complexes and abnormally distributed α-granules, some of which were unusually large (Fig. 3B) . Using electron microscopy, we have quantified the surface, maximal and minimal diameters of platelets on sections, which confirmed the increased platelet size ( Table 2 ). Only for case 10 the concentration of granules was significantly increased ( Table 2 ). Electron micrographs of neutrophils from the R1213* cases showed a heterogeneous content of granules but no abnormal cytoplasmic inclusions as observed in some cases with MYH9-related disease ( Supplementary Fig. 4 ).
Abnormal bleeding symptoms comprised menorrhagia and mild subcutaneous bleeding in case 17 and a post-partum bleed in case 21, but were absent in the other cases. The sensorineural hearing loss that segregated with MTP was detected either at birth or in the first decade of life but progressed rapidly to a severe defect requiring bilateral hearing aids in all eight cases. None of the R1213* cases had abnormal renal function or early onset cataract.
Abnormal maturation of DIAPH1 R1213* MKs
Assessment of MK proliferation, differentiation and proplatelet formation of CD34 + stem cell-derived MKs from case 21 and controls on two separate occasions, revealed similar numbers of MK colony forming units (CFU-MK) at day 12 of culture ( Fig. 4A) . However, the MK colonies from case 21 had a higher cell density compared to controls ( Fig. 4B and Supplementary Fig. 5 ). Suspension cultures from case 21 showed a pronounced defect in PPF compared to different controls in two independent experiments (Fig. 4C, D) . In addition, we found numerous MK clusters containing small and large MKs ( Fig. 4D and Supplementary Fig. 6 ) in cultures from case 21, that were not present in control cultures, which hampered analysis of MK ploidy by flow cytometry (Supplementary Fig. 7 ).
Confocal microscopy of control MKs on day 12 of culture showed a partial colocalization of CD61 and filamentous actin (F-actin), which was not observed in MKs from case 21 (Fig. 4E ). There was also aberrant architecture of the cortical F-actin cytoskeleton in MKs from case 21 and small filopodia-like protrusions and F-actin positive junctions at the contact zones of clustered MKs (Fig. 4E) . This is in line with previous studies where DIAPH1 was shown to regulate adherens junctions via the actin network. 31, 32 The R1213* variant is associated with altered DIAPH expression in platelets.
We next investigated the effect of the R1213* variant on DIAPH1 expression in platelets by performing Western blots using an antibody recognizing the DIAPH1 amino-terminus. Whereas in EDTA-anticoagulated platelet lysates from cases 10, 16, 17 and 21 normal expression levels of DIAPH1 were found, in acid-citratedextrose-anticoagulated platelet lysates the 155 kDa band, corresponding to full length DIAPH1 protein, was decreased in intensity compared with controls, while a band of approximately 80 kDa was more intense ( Fig. 5A; Supplementary Fig. 8 and 9). The 80 kDa band did not correspond to any DIAPH1 transcripts listed in Ensembl, but following immunoprecipitation and mass-spectrometry, was found to contain peptide sequences with 57% coverage across the full length of the DIAPH1 protein sequence (Supplementary information). Moreover, this band was also immunoreactive with antibodies recognizing the DIAPH1 carboxyl terminus ( Supplementary Fig. 8A, B) , suggesting that it resulted from limited proteolysis of DIAPH1 in platelets as reported previously. 33 Since DIAPH1 expressed from the R1213* variant allele is predicted to have only a 60 amino acid truncation, it was not possible to resolve the relative contribution of the variant DIAPH1 to either of the immunoreactive bands (Supplementary Fig. 8B ).
Western blots generated from platelets from the R1213* cases also showed increased DIAPH2 and DIAPH3 expression compared with controls ( Fig. 5A) .
Expression of DIAPH2 and DIAPH3 has previously been observed to decrease during MK maturation, 17 which we confirmed by RNA-seq analysis ( Supplementary   Fig. 10 ). Therefore, our observations in the R1213* cases are consistent with platelet formation from MKs with deregulated maturation and support the previous observations in MKs from bone marrow and culture (Fig. 4A, B) . 17 DIAPH1 R1213* and altered platelet cytoskeleton.
Using confocal microscopy, we found that DIAPH1 was localized to the peripheral marginal band in resting platelets from controls, but was distributed throughout the cytoplasm of platelets from the R1213* cases 10 and 16 (Fig. 5B, C) . There was also increased F-actin and α-tubulin staining, and aberrant organization of microtubules compared with controls (Fig. 5B, D, E) . Electron microscopy confirmed microtubule disorganization (Fig. 5F ) and quantification by manual counting revealed approximately 2.6 fold more microtubule coils in platelets from the R1213* cases compared to controls (Fig. 5G) . Incubation of platelets from controls at 4°C caused disassembly of microtubules, which then reassembled to the marginal band after rewarming to 37°C, as previously reported. [22] [23] [24] In contrast, cold incubation or rewarming did not grossly affect the microtubules in platelets from the R1213* cases (Fig. 6A, B) , suggesting that the increased microtubule content resulted from increased microtubule stability.
The formation of stable microtubules is associated with post-translational detyrosination (Glu-tub) and acetylation (ac-tub) of α-tubulin, whereas dynamic microtubules are characterized by unmodified tyrosinated α-tubulin (Tyr-tub). 34, 35 Following treatment with colchicine or cold incubation to destabilize microtubules, platelets from the R1213* cases 10 and 16 showed a higher content of stable detyrosinated and acetylated microtubules, compared with controls ( Fig. 6A-C;   Supplementary Fig. 11 ). During spreading on fibrinogen, platelets from the R1213* cases maintained detyrosinated and acetylated microtubules, whereas these modifications were not rarely detected in controls (Fig. 6D, E) . Platelets from the R1213* cases also displayed an increased content and aberrant organization of Factin, particularly at the platelet cortex where there was increased formation of small filopods (Fig. 6D, E) . Fractionation of the tubulin cytoskeleton by ultracentrifugation revealed higher ac-tub/Tyr-tub and Glu-tub/Tyr-tub band density ratios in the R1213* cases compared with controls, particularly in the polymerized (pellet) microtubule fraction, confirming a higher content of stable microtubules (Fig. 6F-H) .
DIAPH1 R1213* alters cytoskeletal organization in cell lines.
In HEK293FT cells transfected with wild type (DIAPH1 WT) or variant (DIAPH1 R1213*) expression constructs, Western blots confirmed overexpression of both DIAPH1 WT and DIAPH1 R1213* proteins. However, in contrast to platelets from the R1213* cases, expression of DIAPH2 or DIAPH3 was not increased, allowing us to study the effect of the truncated R1213* DIAPH1 variant in isolation (Fig. 7A) .
Transfection of the human adenocarcinoma lung (A549) epithelial cell line with both expression constructs increased the prevalence of F-actin, microtubules and acetylated microtubules compared with adjacent untransfected cells. This effect was more pronounced in DIAPH1 R1213* than in DIAPH1 WT cells (Fig. 7B-D and   Supplementary Fig. 12 ).
Western blot analysis of microtubule fractions showed that DIAPH1 R1213* transfected HEK293FT cells had a higher content of acetylated and detyrosinated microtubules in the polymerized tubulin fraction, compared with DIAPH1 WT or mock-transfected controls (Supplementary Fig. 12 ), thereby reproducing the cytoskeletal alterations found in platelets from the cases. Incubation of the cells with the small molecule FH2-domain inhibitor SMIFH2 did not influence expression of DIAPH1, 2 or 3 ( Fig. 7A) and did not prevent stabilization of microtubules by DIAPH1 R1213* (Fig. 7E, F) . However, SMIFH2 did reduce the increase in F-actin content in cells overexpressing DIAPH1 R1213* (Fig. 7E, F) confirming that the DIAPH1 FH2 domain is critical for the F-actin polymerization.
DISCUSSION
We have identified DIAPH1 as a novel candidate gene for dominant MTP and sensorineural hearing loss by analysis of the largest ever-assembled collection of cases with previously uncharacterized BPD. Essential to this discovery was the annotation of the characteristics of the cases with HPO terms for hematological features and phenotypes in other organ systems, and then statistical analysis to identify similarities in HPO terms between cases. We have previously shown that cluster analysis of HPO terms within a large BPD case collection enabled identification of causal variants in ACTN1 and MYH9 that have been associated with MTP. 7, 9 However, the statistical evidence supporting DIAPH1 as a candidate gene could only be obtained by applying a novel similarity regression method to the phenotype and genotype data. 19 Specifically, similarity regression revealed a hitherto unidentified association between a characteristic phenotype that was ontologically similar for two unrelated index cases and the shared presence of a high impact variant in DIAPH1.
We also showed that the high impact variant in DIAPH1 was the same premature stop variant R1213* in both index cases and that this segregated with MTP and sensorineural hearing loss in a further six pedigree members, thereby confirming linkage with R1213*.
It is noteworthy that DIAPH1 has been identified previously as the candidate gene for non-syndromic sensorineural deafness type Deafness Autosomal Dominant 1 (DFNA1) (ORPHA90635) in a single characterized pedigree, in which hearing loss typically developed later in childhood than in the R1213* cases. 36,37 The causal variant for DFNA1 caused aberrant splicing of DIAPH1 in lymphocyte cDNA that predicted expression of DIAPH1 with an abnormal carboxyl terminus sequence from glutamine 1220, and chain truncation after a further 21 amino acids. 36 No platelet count or volume data are reported for the DFNA1 pedigree preventing a direct comparison with the R1213* pedigrees reported here. However, an important difference is that the DFNA1 variant disrupts only the two final residues in the DIAPH1 DAD domain (1194-autoregulatory basic RRKR motif. Absent expression of DIAPH1 resulting from a homozygous stop-gain variant at codon 778 has been associated previously with short stature, microcephaly and visual impairment without reported hearing or hematological phenotypes. 38 These observations suggest that genetic abnormalities of DIAPH1 may be associated with a range of phenotypes which together constitute a novel group of DIAPH1-related diseases.
MTP and hearing loss may also co-segregate in MYH9-related disorder (MYH9-RD; ORPHA182050) in which abnormal expression of non-muscle myosin heavy chain IIa alters myosin-dependent organelle distribution and F-actin organization, thereby disrupting MK proplatelet formation. 13, 14 Aberrant cytoskeletal organization in inner ear stereocilia has been proposed as a mechanism for hearing loss in MYH9-RD, 16 and may contribute to this phenotype in the DIAPH1 R1213* cases. However, there are also several characteristics of the DIAPH1 R1213* cases that are absent in MYH9-RD. For example, platelets in the R1213* cases were elongated or round, moderately enlarged and contained few membrane complexes, whereas in MYH9-RD, platelets are highly enlarged and contain abundant membrane complexes. Hearing loss was early onset and severe in the R1213* cases but develops in only 35% of MYH9-RD cases, typically after 10 years of age. 10 Cataract and nephropathy are reported in 5% and 21% of MYH9-RD cases respectively, 10 but were absent in the R1213* cases.
Interestingly, mild neutropenia was frequently observed for R1213* cases (Table 1 ).
These observations indicate that DIAPH1 R1213* is distinct from MHY9-related disorder and should be regarded as distinct disorder.
DIAPH1 is a conserved member of the formin protein family, which mediate RhoGTPase dependent assembly of F-actin and microtubule regulation during cytoskeletal remodeling in cytokinesis, organelle trafficking and filopodia formation.
Several mammalian formins mediate cell differentiation and adhesive events required for hematopoiesis. 25, 39 However, a critical negative regulatory role for DIAPH1 is indicated by observations that targeted knockout of the murine DIAPH1 ortholog Drf1 resulted in hyperproliferative myelodysplasia. 40, 41 Consistent with this, DIAPH1 knockdown in cultured human MKs, resulted in increased proplatelet formation. 17 In contrast, overexpression of a constitutively active DIAPH1 in which both the DID and DAD were deleted by artificial mutagenesis (mDiaΔN3), reduced proplatelet formation in cultured human MKs. 17 We also observed reduced proplatelet formation in CD34 + cell-derived MKs from R1213* case 21, suggesting that this variant may also result in constitutive activation of DIAPH1. The MK culture experiments also suggested that the R1213* variant was associated with enhanced MK proliferation as an increased number of cells was present in the separate CFU-MK colonies from case 21. As a consequence of the increased cell density in the CFU-MK colonies, we were unable to confirm this by counting the total number of single MKs. However, ploidy analysis of suspension cultures revealed no obvious differences in MK endomitosis as both large and small MKs were present in cultures from case 21. Further studies are required to evaluate the possibility of a hyperproliferative effect of early MKs due to the R1213* variant.
The hypothesis that the R1213* variant results in constitutively active DIAPH1 is also supported by the prediction that R1213* causes a partial truncation of the autoregulatory DIAPH1 DAD. Mutagenesis of the DAD has been shown previously to increase the formation of stable microtubule networks and F-actin bundles in cell models, 42,43 consistent with loss of the inhibitory DID-interaction. This interaction is mediated in part by a DAD core MDxLLExL motif, which is unaffected by the R1213* variant but also by the DAD basic RRKR motif that is absent in the R1213* variant. 30 This second site of DID-DAD interaction is necessary for complete auto-regulation of DIAPH1 since selective mutagenesis of the basic RRKR motif also conferred constitutive activity to DIAPH1 orthologs, resulting in abnormal F-actin polymerization and altered cell architecture. 43, 44 We provided experimental support for constitutive activation of DIAPH1 by showing disorganization of actin filaments and increased stability and content of microtubules in platelets from the R1213* cases. Overexpression of DIAPH1 R1213* also resulted in increased assembly of actin filaments and stabilization of microtubules in cell lines, thereby reproducing the cytoskeletal alterations observed in platelets from the R1213* cases. These effects on cytoskeletal organization may account directly for the reduced proplatelet formation from MKs derived from the cases, since highly regulated microtubule and F-actin dynamics are necessary for proplatelet extension and branching. 4, 45, 46 It is noteworthy that overexpression of the constitutively active DIAPH1 mDiaΔN3 which reduced proplatelet formation in cultured human MKs, was shown previously to increase polymerization of filamentous actin, similar to that observed with the R1213* variant. However, in MKs overexpressing mDiaΔN3, microtubule stability was reduced showing that the cytoskeletal alterations do not completely reproduce those associated with the R1213* variant. 17 One possible explanation for this difference is that in contrast to R1213*, the mDiaΔN3 model 
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